JESSICA ADAMS: Open Payments
NPI 1992266191 · HALEYVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 4 payments from 4 companies in 2025. Trend: 2023 $430 · 2024 $268 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| PFIZER INC. | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: XIFAXAN, ELIQUIS, Korlym, CAPLYTA.
Industry payments across AL — which companies pay providers there.
